Paul Edward Gross, See Remarks at Clovis Oncology, Inc. (CLVS), sold 495 shares at $5.21 ($3K) on 2019-09-04, disclosed to the SEC on 2019-09-06.
Open-market sale of $3k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.21 | 225 | $1K | 45.5% |
| 2 | $5.21 | 270 | $1K | 54.5% |
| Total | $5.21 avg | 495 | $3K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $2K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |